,Kathleen M. Giacomini,Shiew-Mei Huang,Donald J. Tweedie,Leslie Z. Benet,Kim L.R. Brouwer,Xiaoyan Chu,Amber Dahlin,Raymond Evers,Volker Fischer,Kathleen M. Hillgren,Keith A. Hoffmaster,Toshihisa Ishikawa,Dietrich Keppler,Richard B. Kim,Caroline A. Lee,Mikko Niemi,Joseph W. Polli,Yuicchi Sugiyama,Peter W. Swaan,Joseph A. Ware,Stephen H. Wright,Sook Wah Yee,Maciej J. Zamek-Gliszczynski,Lei Zhang

Abstract:Key PointsMembrane transporters are increasingly being recognized as important determinants of pharmacokinetics and have been found to play a role in the absorption and disposition of many drugs.In this report, the findings of the International Transporter Consortium (ITC), a group of individuals from academia, industry and regulatory agencies with expertise in membrane transporters, are presented. The goals of the ITC were to identify key transporters with a role in drug absorption and disposition; evaluate methodologies for characterization of drug transporter interactions; and develop criteria to inform the conduct of clinical drug–drug interaction (DDI) studies focused on transporters, which could be presented in the form of decision trees.The key transporters, P-glycoprotein (P-gp, ABCB1); breast cancer resistance protein (BCRP); organic anion transporters (OAT1 and OAT3); organic cation transporter (OCT2); and organic anion transporting polypeptides (OATP1B1 and OATP1B3), described in this report were selected based on evidence in the literature demonstrating that the transporters play a role in governing drug absorption and disposition and in mediating clinical DDIs.For each of the key transporters, substrate and inhibitors and methodologies for evaluating its function are described. The clinical significance of each transporter is discussed.An overview of the methods for studying drug interactions with transporters is presented including cell- and membrane-based systems, intact organs and in vivo models.A section on computational modelling algorithms using information from crystal structures and ligands is included to inform readers about the use of in silico methods to gain information about transporter–substrate interactions.A detailed discussion and suggested decision trees related to studying membrane transporters in drug development are described. The focus of the decision trees is on informing clinical DDI studies.

The Role of Drug Transporters in the Pharmacokinetics of Antibiotics

Classification of renal transporters and their roles on the renal clearance of antibiotics

Research progress in toxic effects of antitumor drugs based on drug transporter

Role of Transporters in the Drug Excretion and Its Significance in New Drug Development

The Physiological Role of Drug Transporters

Transporter-Mediated Drug-Drug Interactions and Their Significance.

The Role of ABCB1, ABCG2, and SLC Transporters in Pharmacokinetic Parameters of Selected Drugs and Their Involvement in Drug–Drug Interactions

The Role of Transporters in the Drug Absorption,Distribution and Elimination and its Significance in the New Drug Development

Xenobiotic transporters: ascribing function from gene knockout and mutation studies.

Transporter-mediated drug-drug interactions: regulatory guidelines, in vitro and in vivo methodologies and translation, special populations, and the blood-brain barrier

Advances in Intestinal Transporters for the Absorption of Drugs

Study on transport mechanism of quinolones

Membrane transporters in drug development

Overview: Role of Drug Transporters in Drug Disposition and Its Clinical Significance.

Drug Transporters in the Kidney: Perspectives on Species Differences, Disease Status, and Molecular Docking

Pharmacokinetics roles of organic anion transporting polypeptides

Liver Transporters in Hepatic Drug Disposition: an Update

Transporter-mediated natural product-drug interactions

Advances in Drug-drug Interactions Mediated by Organic Anion Trans-porting Polypeptides

Role of organic cation transporters in drug–drug interaction

In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery